ESC 365 - Standard-of-care combination treatment rescues GFR decline and cardiac damage in a novel cardiovascular-kidney-metabolic syndrome mouse model with chronic kidney disease and HFpEF

CBS PREMIUM ACCESS

Standard-of-care combination treatment rescues GFR decline and cardiac damage in a novel cardiovascular-kidney-metabolic syndrome mouse model with chronic kidney disease and HFpEF

Session: Late-breaking science poster session

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Speaker: Doctor A. Van Koppen (Den Haag, NL)

Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

Add to my library

About the speaker

Doctor Arianne Van Koppen

TNO Research, Den Haag (Netherlands (The))

2 presentations

0 follower

6 more presentations in this session

LncRNAs in response to endoplasmic reticulum stress: novel players in abdominal aorta aneurysm pathophysiology.

Speaker: Mr R. Almendra-Pegueros (Barcelona, ES)

Exploring the therapeutic potential of cannabidiol and its carboxylic acid in low-grade inflammation and atherosclerosis progression

Speaker: Associate Professor M. Maly (Prague, CZ)

Cold storage of ultrathin cardiac slices to preserve the native electrophysiological response to physiological stimuli

Speaker: Miss C. Lopez Andres (Zaragoza, ES)

miR-652-3p as potential biomarker in the early diagnosis of chemotherapy-induced cardiotoxicity

Speaker: Ms M. Vilar Sanchez (Santiago de Compostela, ES)

The pro-atherogenic effects of CXCL5 haploinsufficiency

Speaker: Ms R. Sanchez-Hodge (Chapel Hill, US)

Access the full session

Late-breaking science poster session

Speakers: Doctor A. Van Koppen, Mr R. Almendra-Pegueros, Associate Professor M. Maly, Miss C. Lopez Andres, Ms M. Vilar Sanchez...

About the event

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources